Zoll lawsuit brings “aggressive” response from Alsius
This article was originally published in Clinica
Temperature management specialist Alsius has said it will “respond aggressively” to a patent infringement lawsuit brought against it by resuscitation technology company Zoll Medical. According to Alsius, the lawsuit claims it has infringed two temperature management patents that Zoll (Chelmsford, Massachusetts) acquired from an unnamed company that was a former rival of Alsius’ and is now defunct. However, Alsius said that Zoll’s patents are invalid and that it retains a dominant patent position in intravascular cooling that “precludes any competitor from marketing an intravascular cooling catheter for therapeutic hypothermia in patients who have had cardiac arrest or heart attack”. The Irvine, California-based firm also said that Zoll has not yet sold any products based on the two patents.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals